DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 211553
Email this page to a colleague
» See Plans and Pricing
NDA 211553 describes CALCIUM CHLORIDE 10%, which is a drug marketed by Am Regent, Intl Medication Sys, Medefil Inc, and Hospira, and is included in four NDAs. It is available from three suppliers. Additional details are available on the CALCIUM CHLORIDE 10% profile page.
The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.
The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.
Summary for 211553
| Tradename: | CALCIUM CHLORIDE 10% |
| Applicant: | Medefil Inc |
| Ingredient: | calcium chloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211553
| Physiological Effect | Increased Coagulation Factor Activity |
Suppliers and Packaging for NDA: 211553
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CALCIUM CHLORIDE 10% | calcium chloride | INJECTABLE;INJECTION | 211553 | ANDA | Medefil, Inc. | 64253-900 | 64253-900-36 | 60 SYRINGE, PLASTIC in 1 BOX (64253-900-36) > 10 mL in 1 SYRINGE, PLASTIC (64253-900-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
| Approval Date: | May 1, 2019 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
